The invention belongs to the technical field of biomedicines, and in particular relates to application of seaweed polysaccharides. The seaweed polysaccharides can be taken as preparations for preparing anti-viral or immune medicines.
Cell models and in-vivo animal experiments show that the seaweed polysaccharides can be used for significantly enhancing the animal
immunity, and can also be used for promoting the generation of
cell factors, the
typing of T lymphocytes and the proliferation of
mouse spleen cells so as to ensure that cellular
immune reaction can be activated. The functional seaweed polysaccharides disclosed by the invention are natural polysaccharides which are extracted from seaweeds such as large seaweeds and kelps, gulfweeds, grateloupia sparsa,
eucheuma muricatum, ulva pertusa kjellm, enteromorpha,
gracilaria,
ascophyllum nodosum and scytosiphon lomentaria, and can also be low-molecular-weight seaweed polysaccharides or seaweed oligosaccharides which are prepared by degrading the seaweed polysaccharides by virtue of different preparation methods. According to the application disclosed by the invention, a
polysaccharide extract of single seaweed or a
polysaccharide extract mixture of a variety of seaweeds can be taken as a novel anti-viral and immune enhancing agent to be applied to feeds of
livestock, poultry, fish, shrimps and
shellfish, and has wide application prospects.